Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Resilience provides end-to-end biomanufacturing solutions—including process development, drug substance/product manufacturing—for complex medicines such as biologics, vaccines, nucleic acids, cell therapies, and gene therapies. The company’s focus is on enabling rapid scale-up and robust supply chains for partners in the biotech/pharma sector. It does not develop its own clinical candidates but supports over 60 molecules through partnerships with pharma/biotech companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on National Resilience, Inc..